ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Revolution Medicines
The Senior Director, Global Commercial Development leads global commercial strategy and lifecycle development for Revolution Medicines' pancreatic cancer portfolio, including daraxonrasib and zoldonrasib. This role involves translating clinical evidence and market insights into integrated commercial strategies, forecasting patient and revenue scenarios, and preparing for future launches across multiple disease settings. The position requires strong cross-functional leadership to align with clinical, medical, and access teams while driving portfolio investment decisions.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
MarketBeatVictory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Simply Wall StRevolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
GlobeNewswireRevolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Yahoo FinanceRevolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Director Global Oncology Marketing SacTMT Breast Cancer
MSD
Global Commercial Head, IO GU & Women’s Cancers
AstraZeneca
Director Global Oncology Marketing GI Cancers
MSD
Global Marketing Director
Merck & Co., Inc.
Senior Director, Global Commercial, panKRAS
AstraZeneca
Director Global Oncology Marketing sac-TMT
MSD
